Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells

Histone deacetylase inhibitors (HDIs) are a group of potent epigenetic drugs which have been investigated for their therapeutic potential in various clinical disorders, including hematological malignancies and solid tumors. Currently, several HDIs are already in clinical use and many more are on cli...

Full description

Bibliographic Details
Main Authors: Anna Wawruszak, Joanna Kalafut, Estera Okon, Jakub Czapinski, Marta Halasa, Alicja Przybyszewska, Paulina Miziak, Karolina Okla, Adolfo Rivero-Muller, Andrzej Stepulak
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Cancers
Subjects:
cancer
HDI
HDAC
EMT
MET
cadherin
catenin
vimentin
migration
invasion
Online Access:https://www.mdpi.com/2072-6694/11/2/148

Internet

https://www.mdpi.com/2072-6694/11/2/148

Similar Items